When more is more: the role of additional upfront therapy in pulmonary arterial hypertension.

Niedermeyer, Shannon; Hassoun, Paul

Niedermeyer, Shannon; Hassoun, Paul.

Afiliação

Niedermeyer S; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Hassoun P; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.

ERJ Open Res ; 9(1)2023 Jan.

Article em En | MEDLINE | ID: mdl-36687364

ABSTRACT

ABSTRACT

Early combination therapy targeting several relevant pathogenic pathways, including the prostacyclin pathway, is likely to be of benefit to most patients with PAH https//bit.ly/3GisHnA.

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: ERJ Open Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google